Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2011
11/03/2011US20110269741 Novel compositions and methods of use
11/03/2011US20110269739 Kinase inhibitors
11/03/2011US20110269668 Fused Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/03/2011US20110266533 Compounds for electronic devices
11/03/2011DE102010018982A1 New substituted imidazolonaphthalene compounds, useful e.g. as pigments and colorants for dyeing purposes and decorative purposes, as watercolor paints and inks for inkjet printers, and as material for leak testing of closed systems
11/03/2011CA2791020A1 [5,6] heterocyclic compound
11/02/2011EP2383816A1 Organic electroluminescent device
11/02/2011EP2383813A1 Light-emitting element material and light-emitting element
11/02/2011EP2383267A1 Substituted sulfonamide derivatives
11/02/2011EP2383259A1 New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds
11/02/2011EP2382215A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
11/02/2011EP2382214A1 Method of preparing (+)-1,4-dihydro-7-ý(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl¨-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
11/02/2011EP2382213A1 One-step process for preparing paliperidone and its oxalate salt
11/02/2011EP2382204A1 Pyrimidine derivatives as gpcr modttlators for use in the treatment of obesity and diabetes
11/02/2011EP2382191A1 Novel benzenesulfonamides as calcium channel blockers
11/02/2011EP2381944A1 Anti-viral compounds, treatment, and assay
11/02/2011EP2381779A1 Selective inhibitors of akt and methods of using same
11/02/2011EP2381777A1 Azaindole derivatives as kinase inhibitors
11/02/2011EP2294068B1 1,3-dihydro-2h-pyrrolo[3,2-b]pyridin-2-one derivatives, preparation thereof and therapeutic uses thereof
11/02/2011EP2278973B1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
11/02/2011EP2245014B1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
11/02/2011EP1966208B1 (1-AZA-BICYCLO[3.3.1]NON-4-YL)-[5-(1H-INDOL-5-YL)-HETEROARYL]-AMINES AS CHOLINERGIC LIGANDS OF THE N-AChR FOR THE TREATMENT OF PSYCHOTIC AND NEURODEGENERATIVE DISORDERS
11/02/2011CN102232074A Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
11/02/2011CN102232073A New compounds I
11/02/2011CN101547692B Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound having specific structure
11/01/2011US8048901 5-{3-[3-(5-Methyl-2-m-tolyloxazol-4-ylmethoxy)cyclohexyloxy]-propyl}-2H-tetrazole; metabolic disorders, insulin resistance, dyslipidemia, Syndrome X
11/01/2011US8048892 Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
11/01/2011US8048885 Organic compounds
11/01/2011CA2649521C Novel piperazine compound, and use thereof as hcv polymerase inhibitor
11/01/2011CA2645257C Sulfonyl benzimidazole derivatives
11/01/2011CA2490277C Use of vasopeptidase inhibitors in the treatment of nephropathy
11/01/2011CA2481261C Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
11/01/2011CA2395459C Use of quinoline and quinolizinone derivatives as chemotherapeutic agents
10/2011
10/27/2011WO2011133795A2 Beta-carbolines as inhibitors of haspin and dyrk kinases
10/27/2011WO2011133750A1 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011WO2011133637A2 Compounds and methods for kinase modulation, and indications therefor
10/27/2011WO2011133388A1 Pyrrolopyridine inhibitors of kinases
10/27/2011WO2011133182A1 Modulators of 5-ht receptors and methods of use thereof
10/27/2011WO2011133039A2 Novel conjugates of cc-1065 analogs and bifunctional linkers
10/27/2011WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011WO2011132017A1 Pyrido[3,4-d]pyrimidinyl acetamide derivatives as trpa1 modulators
10/27/2011WO2011086306A9 5-oxo-5, 8-dihydropyrido [2, 3-d] pyrimidine derivatives as camkii kinase inhibitors for treating cardiovascular diseases
10/27/2011WO2011056511A3 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
10/27/2011WO2011055932A3 Organic compound, organic electronic device using same, and terminal for same
10/27/2011WO2010078421A8 Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds
10/27/2011US20110263629 Amides of diazabicyclooctanes and uses thereof
10/27/2011US20110263620 Quinoline compounds and their use for treating viral infection
10/27/2011US20110263612 Compounds that modulate intracellular calcium
10/27/2011US20110263595 Compounds and methods for kinase modulation, and indications therefor
10/27/2011US20110263594 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
10/27/2011US20110263593 NOVEL IMIDAZO[1,2-a]PYRIMIDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE, IN PARTICULAR AS MET INHIBITORS
10/27/2011US20110263592 Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
10/27/2011US20110263588 Tricyclic compounds as glutamate receptor modulators
10/27/2011US20110263581 Fused tricyclic compounds as serine-threonine protein kinase and parp modulators
10/27/2011US20110263577 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use
10/27/2011US20110263574 Pirenzepine as otoprotective agent
10/27/2011US20110263560 Organic Compounds
10/27/2011US20110263559 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011US20110263558 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
10/27/2011US20110263549 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
10/27/2011US20110263541 Kinase inhibitors and their use as pharmaceutical agents
10/27/2011US20110263530 Aurora Kinase Modulators and Method of Use
10/27/2011US20110263494 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf-kappab acitivity and use thereof
10/27/2011US20110260138 Bicarbzole containing compounds for oleds
10/27/2011CA2797019A1 Modulators of 5-ht receptors and methods of use thereof
10/27/2011CA2795422A1 Pyrrolopyridine inhibitors of kinases
10/26/2011EP2380890A1 New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
10/26/2011EP2380889A2 Thiazolyl MGLUR5 antagonists and methods for their use
10/26/2011EP2380881A1 Novel bicyclic heterocyclic compound
10/26/2011EP2380878A1 Cyclic compound having hetero atom
10/26/2011EP2380631A1 Heteroaryl derivatives as DGAT1 inhibitors
10/26/2011EP2379561A2 Mlk inhibitors and methods of use
10/26/2011EP2379559A2 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
10/26/2011EP2379554A1 Naphthyridin-2 (1 h)-one compounds useful as antibacterials
10/26/2011EP2379553A1 Bicyclic compounds for the reduction of beta-amyloid production
10/26/2011EP2379552A1 Substituted bicyclic imidazole derivatives as gamma secretase modulators
10/26/2011EP2379551A1 Substituted pyrazolo [3, 4-b]pyridine compounds
10/26/2011EP2379550A1 Piperidine derivatives useful as orexin antagonists
10/26/2011EP2379549A1 7-azaindirubins, 7'azaindirubins, 7,7'-diazaindirubins and the corresponding 3'-oxime ether derivatives thereof, their production and use as a medicament
10/26/2011EP2379548A1 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
10/26/2011EP2379547A1 Pyridopyrimidine derivatives and methods of use thereof
10/26/2011EP2379529A1 Novel compounds
10/26/2011EP2379525A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
10/26/2011EP2379523A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
10/26/2011EP2379515A2 Benzoxazole-based fluorescent metal ion indicators
10/26/2011EP2379513A1 Heteroaryl compounds useful as raf kinase inhibitors
10/26/2011EP2379506A1 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
10/26/2011EP2379071A2 Novel aliphatically substituted pyrazolopyridines, and the use thereof
10/26/2011EP2378877A1 Imidazolinone derivatives as cgrp receptor antagonists
10/26/2011EP2029573B1 Dibenzorylenetetracarboximides as infrared absorbers
10/26/2011EP1991546B1 NOVEL DIBENZO[c,h][1,5]NAPHTHYRIDINES AND THEIR USE AS DNA PROBES
10/26/2011EP1943219B1 5-lipoxygenase-activating protein (flap) inhibitors
10/26/2011EP1518855B1 Diaminopyrimidinecarboxa mide derivative
10/26/2011EP1425010B1 Substituted indoles and their use as integrin antagonists
10/26/2011CN1980934B Novel indole derivatives as selective androgen receptor modulators (sarms)
10/26/2011CN102227486A Organic electroluminscent device using electroluminescent compounds
10/26/2011CN102227426A Benzonaphtyridine compounds used as inhibitors of autotaxin
10/26/2011CN102227425A Azaindazole compounds as ccr1 receptor antagonists
10/26/2011CN102227422A Heterocyclic jak kinase inhibitors
10/26/2011CN102225937A Antineoplastic alkaloid compound, and its medicine composition, preparation method and application
1 ... 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 ... 646